Fecal Molecular Susceptibility-guided Hp First-line Therapy
Fecal Molecular Susceptibility-guided Hp First-line Therapy
Not yet recruiting · NCT07405684 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fecal Molecular Susceptibility-guided Hp First-line Therapy | HELICOBACTER PYLORI INFECTIONS | Not yet recruiting | Phase 4 | 2026-02-12 | NCT07405684 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiaotong University | Shanghai | China | 2 |
| Shanghai Jiangong Hospitail. | Shanghai | China | 2 |
| Shanghai Tenth People Hospital | Shanghai | China | 2 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 37 |